Global patent landscape of programmed cell death 1: implications of the rapid expansion
{{output}}
Introduction: Inhibitors of programmed cell death 1 (PD-1) and its ligands are producing a paradigm shift in cancer treatment. The promising clinical outcomes and a multi-billion dollar market have prompted active research and de... ...
